Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Role of Optical Coherence Tomography in Managing Diabetic Maculopathy and Retinopathy

The Role of Optical Coherence Tomography in Managing Diabetic Maculopathy and Retinopathy Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 EDITORIAL The Role of Optical Coherence Tomography in Managing Diabetic Maculopathy and Retinopathy Suber S. Huang, MD, MBA,* and Chad Marcantonio ince the first publication of data using optical coherence tomography (OCT) in 1991 and the release S of the first commercially available OCT in 1995, OCT has been at the forefront of the clinical management of retina and macular diseases. Increased resolution, speed, and its noninvasive nature are major reasons why OCT imaging has outpaced fluorescein angiography (FA) and fundus imag- ing as the primary technology for macular and optic nerve imaging. The ability to detect anatomic alter- ations of 8 to 10 μm has made OCT the mainstay of virtually all clinical trials for retinal disease. The review article by Ruia et al is an excellent summary of previous research on the diagnostic find- ings of diabetic macular edema (DME) on OCT and its clinical relevance and posits the need for a stan- dardized methodology to categorize DME. The article reviews the historical perspective of the Early Treatment Diabetic Retinopathy Studies and illustrates that the descriptive features of focal and diffuse edema noted on clinical and angiographic examination are shifting http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

The Role of Optical Coherence Tomography in Managing Diabetic Maculopathy and Retinopathy

Download PDF
2 pages

Loading next page...
 
/lp/wolters-kluwer-health/the-role-of-optical-coherence-tomography-in-managing-diabetic-enap0i30jL

References (15)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2016 by Asia Pacific Academy of Ophthalmology
ISSN
2162-0989
eISSN
2475-5028
DOI
10.1097/APO.0000000000000231
pmid
27632027
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 EDITORIAL The Role of Optical Coherence Tomography in Managing Diabetic Maculopathy and Retinopathy Suber S. Huang, MD, MBA,* and Chad Marcantonio ince the first publication of data using optical coherence tomography (OCT) in 1991 and the release S of the first commercially available OCT in 1995, OCT has been at the forefront of the clinical management of retina and macular diseases. Increased resolution, speed, and its noninvasive nature are major reasons why OCT imaging has outpaced fluorescein angiography (FA) and fundus imag- ing as the primary technology for macular and optic nerve imaging. The ability to detect anatomic alter- ations of 8 to 10 μm has made OCT the mainstay of virtually all clinical trials for retinal disease. The review article by Ruia et al is an excellent summary of previous research on the diagnostic find- ings of diabetic macular edema (DME) on OCT and its clinical relevance and posits the need for a stan- dardized methodology to categorize DME. The article reviews the historical perspective of the Early Treatment Diabetic Retinopathy Studies and illustrates that the descriptive features of focal and diffuse edema noted on clinical and angiographic examination are shifting

Journal

The Asia-Pacific Journal of Ophthalmology – Wolters Kluwer Health

Published: Oct 1, 2016

There are no references for this article.